Gobiquity Mobile Health company presentation from OIS@AAO 2015

1. Andrew Burns
CEO

2. We enable early detection and prevention
of vision impairment through broad access
of specialized mobile diagnostic solutions
Gobiquity Mobile Health
we create #BrighterFutures

3. global vision impairment | 2020
(1) World Health Organization, 2010.
(2) World Health Organization, 2011.
(3) Vision 2020, World Health Organization, 2007.
400M affected
400M affected(1)
Convergence of a Huge Medical Need with Ubiquitous
Technology Adoption
80% treatable(2)
disproportionate amount of eye
care professionals to address
this market
1 ophthalmologist
250,000general
population(3)

4. (4))Spyglass Consulting Group, 2015.
(5) Havas Worldwide, Juke 2015
(6) 2014 HIMSS Analytic Cloud Survey
Convergence of a Huge Medical Need with Ubiquitous
Technology Adoption
technology adoption & platform evolution
Physician smartphone
adoption is
nearly universal(4)
92% of healthcare
providers see value of cloud
computing(6)
70% of consumers
want mHealth to monitor
every aspect of health (5)

5. 25% of children have a vision problem that affects their
ability to learn (7)
Amblyopiacosts our country $23 billion
annually (8)
20% of children in the US have Amblyopia Risk Factors, yet < 20% of
preschoolers are screened (9) (!0)
Amblyopia can be eradicated, if identified
early(11)
Pediatric Vision Screening
(7))American Public Health Association, American Optometric Association and the
Vision Council of America
(8) Economic Analysis of the Consequences of Failure to Prevent Childhood
Blindness from Ambloypia, William E. Gibson, Ph.D.
(9) Donahue, Silbert; JAAPOS, 2013
(10) Children’s Eye Foundation. Accessed June 16, 2014.
(11) Holmes JM, Lazar EL, Melia M, et al. Arch Ophthalmol.2011.

6. <10% penetration with traditional
single-purpose photo screening
81% wanting to adopt for their
practice (12)
AAP AAPOS USPSTF
Pediatric Vision Screening
large, unsaturated market
endorsed by medical experts
(12))MedLIVE. January, 2015.

7. Effectively and efficiently identifies Amblyopia Risk Factors (ARFs)
1 2 3
GoCheck Kids Photoscreener
• Clinically validated
• Better economics
• Easy, familiar & mobile
• Convenient integration
the first pediatric photoscreener on a smartphone

8. we #EndAmblyopia

9. GCK Photoscreener Commercial Momentum
578
0
100
200
300
400
500
600
700
Jan Feb Mar Apr May Jun Jul Aug Sep Oct
Providers
6,403
0
1000
2000
3000
4000
5000
6000
7000
Jan Feb Mar Apr May Jun Jul Aug Sep Oct
Photoscreenings / mo
• > 39,000 screenings with 2,500 ARF patients identified
• Surpassed 1,500 screenings/week in Q3 (108% QoQ growth)
• 578 providers across 150 sites in 25 states
• Enterprise clients: 40 Engaged / 9 Trials / 3 Signed
• Entry into school vision screening with 2 districts in September
• Sales pipeline of ~4,000 providers

10. Our flagship innovation, GoCheck Kids has evolved into the
industry’s first comprehensive vision screening app
Market Demand for Product Evolution
AAP Recommends
"GoCheck Kids is a fast, easy test,
and very effective.
I was quite surprised to find so many
children with risk factors, especially
the little ones. Without this tool, those
problems wouldn’t have been
picked up until they’re older."
Karl Kosse, MD,
Kosse Pediatrics, St. Joseph, Missouri

11. GoCheck Kids

12. GoCheck Kids Screening Suite
TAM @ $1 billion
Gobiquity Evolution
Comprehensive Digital
Diagnostics Platform
today

13. Explosive population growth
Increased number of undiagnosed
(in the United States alone)
Age Related Macular Degeneration
2.3 million undiagnosed cases of AMD (13)
Diabetic Retinopathy
> 40% of diabetics have DR (14)
29% of diabetics with DR are undiagnosed (15)
Gobiquity Evolution
(13) Right Diagnosis. July 2015.
(14) CDC Diabetic Retinopathy Fact Sheet. 2015.
(15) National Diabetes Statistics Report, 2014 (released June 10, 2014)
future trends

14. Health Professionals
Consumers
Adult tools & resources
TAM for AMD & Diabetic
Retinopathy @ $3 billion
Image Acquisition & Analysis
Retina vision screening &
monitoring
Refractive screening
Photo documentation
Gobiquity Evolution
future vision

15. Diverse, Hybrid Team Across Domain Expertise
Expertise in mobile & imaging software development, ophthalmology,
commercialization, and regulatory
Positioned for Continued Growth
CEO: Andrew Burns
Epocrates, Sermo, CVS
Caremark
CCO: Kent Westervelt
Epocrates, Cerner, CVS
Caremark
Founder & Director of Software:
Tommy Tam
Accela, Inc., MOTO Development
Group, RAE Systems, Apple
Director, Practice Development:
Darcy Wendel
Revision Optics, LENSAR, Houston
Eye Clinics, Sonomed Escalon
SVP Strategic Marketing:
Michael Marett
Sermo, Kyp, Digital Health
Innovator
Founder & CIO:
David Huang, MD, PhD
Transformative Inventor in
Ophthalmology

16. Series A: Primary investors InterWest Partners
& Marc Benioff (salesforce.com)
Series B (commenced): $8 million - $10 million
Positioned for Continued Growth

17. Uniquely positioned mobile vision diagnostic solutions
focused on large, untapped markets
Design and develop SAAS-based services with demonstrated
clinical accuracy to improve patient outcomes
Commercial Validation
Enable > 70% of pediatricians, plus breadth of healthcare
constituents, that want access to a low-cost, efficient, and
accurate vision screening platform
Team with deep mHealth and optics experience
Expertise in mobile & imaging software development,
ophthalmology, commercialization, and regulatory
Summary
“It’s a Homerun”
Robertson Pediatrics

18. thank you
#EndAmblyopia |#BrighterFutures
gocheckkids.com